Replies to post #316517 on Avid Bioservices Inc (CDMO)

[BioBS2012]

LY3022855 (IMC-CS4) is being investigated in phase I clinical trials, including a collaboration clinical trial with another immuno-oncology agent.

DO YOU SEE THE PS THAT IS BS BEING TESTED WITH ICS-CS4 in this list below? I DON'T SEE IT !!

https://clinicaltrials.gov/ct2/results?term=LY3022855+&type=&rslt=&age_v=&gndr=&cond=&intr=&titles=&outc=&spons=&lead=&id=&cntry1=&state1=&cntry2=&state2=&cntry3=&state3=&locn=&phase=4&phase=0&sfpd_s=&sfpd_e=&lupd_s=&lupd_e=

Hmmmmm....anyone sense PS Targeting

Only sense I get is a foul smell of crap.

[revenue_monster]

no i sense BS.